Assessment of the antidiabetic activity of epicatechin in streptozotocin-diabetic and spontaneously diabetic BB/E rats
Keyword(s):
(−)-Epicatechin has previously been suggested to rapidly reverse alloxan diabetes in rats. We have assessed the therapeutic value of the compound in two further animal models of insulin-dependent diabetes mellitus, namely streptozotocin – diabetic rats and the spontaneously diabetic BB/E rat. There was no indication of a reversal of established diabetes in either the streptozotocin-diabetic or the spontaneously diabetic BB/E rats. Moreover, epicatechin also failed to halt the progression of the disease in prediabetic BB/E rats. Earlier claims of the potential use of epicatechin as an antidiabetic agent must therefore be treated with some caution.
2005 ◽
Vol 21
(01)
◽
pp. 51-56
◽
1998 ◽
Vol 41
(2)
◽
pp. 101-111
◽
1995 ◽
Vol 268
(6)
◽
pp. H2366-H2374
◽
1987 ◽
Vol 252
(1)
◽
pp. E13-E20
◽
1997 ◽
Vol 273
(4)
◽
pp. H1888-H1893
◽
1996 ◽
Vol 271
(1)
◽
pp. H192-H202
◽
2003 ◽
Vol 82
(4)
◽
pp. 322-325
◽
1991 ◽
Vol 90
(6)
◽
pp. S15-S21
◽
2010 ◽
Vol 29
(10)
◽
pp. 865-871
◽